Different pathways of macrophage activation and polarization

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 69, Issue , 2015, Pages 496-502

  Juhas, Ulana ^a   Ryba Stanisławowska, Monika ^a   Szargiej, Patryk ^a   Myśliwska, Jolanta ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Circulating monocytes; M1 M2 macrophage polarization; Macrophage surface receptors; Macrophage transcription factors

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, HUMAN;

HUMAN; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MONOCYTE; PHYSIOLOGY;

CYTOKINES; HUMANS; MACROPHAGE ACTIVATION; MONOCYTES; NITRIC OXIDE SYNTHASE TYPE II;

EID: 84973426190     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1150133     Document Type: Review

References (68)

1. Alikhan M.A., Ricardo S.D.: Mononuclear phagocyte system in kidney disease and repair. Nephrology, 2013; 18: 81-91
2. Ambarus C.A., Krausz S., van Eijk M., Hamann J., Radstake T.R., Reedquist K.A., Tak P.P., Baeten D.L.: Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods, 2012; 375: 196-206
3. Anderson K.L., Nelson S.L., Perkin H.B Smith K.A., Klemsz M.J., Torbett B.E.: PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J. Biol. Chem., 2001; 276: 7637-7642
4. Baker R.G., Hayden M.S., Ghosh S.: NF-κB, inflammation and metabolic disease. Cell Metab., 2011; 13: 11-22
5. Banerjee S., Cui H., Xie N., Tan Z., Yang S., Icyuz M., Thannickal V.J., Abraham E., Liu G.: miR-125a-5p regulates differential activation of macrophages and inflammation. J. Biol. Chem., 2013; 288: 35428-35436
6. Bannon P., Wood S., Restivo T., Campbell L., Hardman M.J., Mace K.A.: Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis. Model. Mech., 2013; 6: 1434-1447
7. Barros M.H.M, Hauck F., Dreyer J.H., Kempkes B., Niedobitek G.: Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages. PLoS One, 2013; 8: e80908
8. Bouhlel M.A., Derudas B., Rigamonti E., Dièvart R., Brozek J., Haulon S., Zawadzki C., Jude B., Torpier G., Marx N., Staels B., Chinetti-Gbaguidi G.: PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab., 2007; 6: 137-143
9. Cai D.H., Wang D., Keefer J., Yeamans C., Hensley K., Friedman A.D.: C/EBPα:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBPα homodimers or AP-1. Oncogene, 2008; 27: 2772-2779
10. Cassetta L., Cassol E., Poli G.: Macrophage polarization in health and disease. Scientific World Journal, 2011; 11: 2391-2402
11. Celada A., Borràs F.E., Soler C., Lloberas J., Klemsz M., van Beveren C., McKercher S., Maki R.A.: The transcription factor PU.1 is involved in macrophage proliferation. J. Exp. Med., 1996; 184: 61-69
12. Chen Z.Y., Shie J., Tseng C.: Up-regulation of gut-enriched kruppel-like factor by interferon-g in human colon carcinoma cells. FEBS Lett., 2000; 477: 67-72
13. Contreras I., Gómez M.A., Nguyen O., Shio M.T., McMaster R.W., Olivier M.: Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog., 2010; 6: e1001148
14. Dushkin M.I.: Macrophage/foam cell is an attribute of inflammation: mechanisms of formation and functional role. Biochemistry, 2012; 77: 327-338
15. Espinoza-Jiménez A., Peón A.N., Terrazas L.I.: Alternatively activated macrophages in types 1 and 2 diabetes. Mediators Inflamm., 2012; 2012: 815953
16. Fadini G.P., Cappellari R., Mazzucato M., Agostini C., de Kreutzenberg S.V, Avogaro A.: Monocyte-macrophage polarization balance in pre-diabetic. Acta Diabetol., 2013; 50: 977-982
17. Fahy R.J., Doseff A.I., Wewers M.D.: Spontaneous human monocyte apoptosis utilizes a caspase-3-dependent pathway that is blocked by endotoxin and is independent of caspase-1. J. Immunol., 1999; 163: 1755-1762
18. Feinberg M.W., Cao Z., Wara A.K., Lebedeva M.A., Senbanerjee S., Jain M.K.: Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem., 2005; 280: 38247-38258
19. Galli S.J., Borregaard N., Wynn T.A.: Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol., 2011; 12: 1035-1044
20. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., Gregory L., Lonie L., Chew A., Wei C.L., Ragoussis J., Natoli G.: Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity., 2010; 32: 317-328
21. Gordon S., Taylor P.R.: Monocyte and macrophage heterogeneity. Nat. Rev. Immunol., 2005; 5: 953-964
22. Hayden M.S., Ghosh S.: Shared principles in NF-κB signaling. Cell, 2008; 132: 344-362
23. Hu X., Chen J., Wang L., Ivashkiv L.B.: Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol., 2007; 82: 237-243
24. Huang J.T., Welch J.S., Ricote M., Binder C.J., Willson T.M., Kelly C., Witztum J.L., Funk C.D., Conrad D., Glass C.K.: Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase. Nature, 1999; 400: 378-382
25. Hull R.P., Srivastava P.K., D'Souza Z., Atanur S.S., Mechta-Grigoriou F., Game L., Petretto E., Cook H.T., Aitman T.J., Behmoaras J.: Combined ChIP-Seq and transcriptome analysis identifies AP-1/JunD as a primary regulator of oxidative stress and IL-1β synthesis in macrophages. BMC Genomics, 2013; 14: 92
26. Ivashkiv L.B.: Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur. J. Immunol., 2011; 41: 2477-2481
27. Karpurapu M., Wang X., Deng J., Park H., Xiao L., Sadikot R.T., Frey R.S., Maus U.A., Park G.Y, Scott E.W., Christman J.W.: Functional PU.1 in macrophages has a pivotal role in NF-κB activation and neutrophilic lung inflammation during endotoxemia. Blood, 2011; 118: 5255-5266
28. Kernbauer E., Maier V., Stoiber D., Strobl B., Schneckenleithner C., Sexl V., Reichart U., Reizis B., Kalinke U., Jamieson A., Müller M., Decker T.: Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection. PLoS Pathog., 2012; 8: e1002763
29. Kittan N.A., Allen R.M., Dhaliwal A., Cavassani K.A., Schaller M., Gallagher K.A., Carson W.F. 4th, Mukherjee S., Grembecka J., Cierpicki T., Jarai G., Westwick J., Kunkel S.L., Hogaboam C.M.: Cytokine induced phenotypic and epigenetic signatures are key to establishing specific macrophage phenotypes. PLoS One, 2013; 8: e78045
30. H17 responses. Nat. Immunol., 2011; 12: 231-238
31. Lawrence T., Natoli G.: Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol., 2011; 11: 750-761
32. Lehtonen A., Veckman V., Nikula T., Lahesmaa R., Kinnunen L., Matikainen S., Julkunen I.: Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages. J. Immunol., 2005; 175: 6570-6579
33. Liao X., Sharma N., Kapadia F., Zhou G., Lu Y., Hong H., Paruchuri K., Mahabeleshwar G.H., Dalmas E., Venteclef N., Flask C.A., Kim J., Doreian B.W., Lu K.Q., Kaestner K.H., Hamik A., Clément K., Jain M.K.: Krüppel-like factor 4 regulates macrophage polarization. J. Clin. Invest., 2011; 12: 2736-2749
34. Liu Y., Nonnemacher M.R., Wigdahl B.: CCAAT/enhancer-bin-ding proteins and the pathogenesis of retrovirus infection. Future Microbiol., 2009; 4: 299-321
35. Lloberas J., Soler C., Celada A.: The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today, 1999; 20: 184-189
36. Locati M., Mantovani A., Sica A.: Macrophage activation and polarization as an adaptive component of innate immunity. Adv. Immunol., 2013; 120: 163-184
37. Mancino A., Lawrence T.: Nuclear factor-κB and tumor-associated macrophages. Clin. Cancer Res., 2010; 16: 784-789
38. Murray P.J., Wynn T.A.: Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol., 2011; 11: 723-737
39. Natoli G., Ghisletti S., Barozzi I.: The genomic landscapes of inflammation. Genes Dev., 2011; 25: 101-106
40. Nazimek K., Bryniarski K.: Aktywność biologiczna makrofagów w zdrowiu i chorobie. Postȩpy Hig. Med. Dośw., 2012; 66: 507-520
41. Negishi H., Ohba Y., Yanai H., Takaoka A., Honma K., Yui K., Matsuyama T., Taniguchi T., Honda K.: Negative regulation of Toll-like-receptor signaling by IRF-4. Proc. Natl. Acad. Sci. USA, 2005; 102: 15989-15994
42. Nishiyama C., Nishiyama M., Ito T., Masaki S., Masuoka N., Yamane H., Kitamura T., Ogawa H., Okumura K.: Functional analysis of PU.1 domains in monocyte-specific gene regulation. FEBS Lett., 2004; 561: 63-68
43. Noti J.D., Johnson A.K., Dillon J.D.: The leukocyte integrin gene CD11d is repressed by gut-enriched Kruppel-like factor 4 in myeloid cells. J. Biol. Chem., 2005; 280: 3449-3457
44. Nucera S., Biziato D., De Palma M.: The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int. J. Dev. Biol., 2011; 55: 495-503
45. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A.: Macrophage-specific PPARg controls alternative activation and improves insulin resistance. Nature, 2007; 447: 1116-1120
46. Ohmori Y., Hamilton T.A.: IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol., 1997; 159: 5474-5482
47. Pang W.J., Lin L.G., Xiong Y., Wei N., Wang Y., Shen Q.W., Yang G.S.: Knockdown of PU.1 AS IncRNA inhibits adipogenesis through enhancing PU.1 mRNA translation. J. Cell. Biochem., 2013; 114: 2500-2512
48. Parihar A., Eubank T.D., Doseff A.I.: Monocytes and macrophages regulate immunity through dynamic networks of survival and cell death. J. Innate Immun., 2010; 2: 204-215
49. Parsa R., Andresen P., Gillett A., Mia S., Zhang X.M., Mayans S., Holmberg D., Harris R.A.: Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes, 2012; 61: 2881-2892
50. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., Glass C.K.: A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ. Nature, 2005; 437: 759-763
51. Rauch I., Müller M., Decker T.: The regulation of inflammation by interferons and their STATs. JAKSTAT, 2013; 2: e23820
52. Rey-Giraud F., Hafner M., Ries C.H.: In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions. PLoS One, 2012; 7: e42656
53. Ricardo S.D., van Goor H., Eddy A.A.: Macrophage diversity in renal injury and repair. J. Clin. Invest. 2008; 118: 3522-3530
54. Rosenbauer F., Owens B.M., Yu L., Tumang J.R., Steidl U., Kutok J.L., Clayton L.K., Wagner K., Scheller M., Iwasaki H., Liu C., Hackanson B., Akashi K., Leutz A., Rothstein T.L., Plass C., Tenen D.G.: Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet., 2006; 38: 27-37
55. Ruffell D., Mourkioti F., Gambardella A., Kirstetter P., Lopez R.G., Rosenthal N., Nerlov C.: A CREB-C/EBPβ cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc. Natl. Acad. Sci. USA, 2009; 106: 17475-17480
56. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., Honma K., Matsuyama T., Yui K., Tsujimura T., Standley D.M., Nakanishi K., Nakai K., Akira S.: The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol., 2010; 11: 936-944
57. Savitsky D., Tamura T., Yanai H., Taniguchi T.: Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother., 2010; 59: 489-510
58. Semple R.K., Chatterjee V.K., O'Rahilly S.: PPARg and human metabolic disease. J. Clin. Invest., 2006; 116: 581-589
59. Smale S.T.: Seqing LPS-induced enhancers. Immunity, 2010; 32: 296-298
60. Szanto A., Balint B.L., Nagy Z.S., Barta E., Dezso B., Pap A., Szeles L., Poliska S., Oros M., Evans R.M., Barak Y., Schwabe J., Nagy L.: STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells. Immunity, 2010; 33: 699-712
61. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T.W., Taniguchi T.: Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature, 2005; 434: 243-249
62. Takeuch O., Akira S.: Epigenetic control of macrophage polarization. Eur. J. Immunol., 2011; 41: 2490-2493
63. Taniguchi T., Ogasawara K., Takaoka A., Tanaka N.: IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol., 2001; 19: 623-655
64. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., Gordon S.: Macrophage receptors and immune recognition. Annu. Rev. Immunol., 2005; 23: 901-944
65. Tiemessen M.M., Jagger A.L., Evans H.G., van Herwijnen M.J, John S., Taams L.S.: CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc. Natl. Acad. Sci. USA, 2007; 104: 19446-19451
66. van Wilgenburg B., Browne C., Vowles J., Cowley S.A.: Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions. PLoS One, 2013; 8: e71098
67. Wang X.F., Wang H.S., Zhang F., Guo Q., Wang H., Wang K.F., Zhang G., Bu X.Z., Cai S.H., Du J.: Nodal promotes the generation of M2-like macrophage and downregulates the expression of IL-12. Eur. J. Immunol., 2014; 44: 173-183
68. Zhou D., Huang C., Lin Z., Zhan S., Kong L., Fang C., Li J.: Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell. Signal., 2013; 26: 192-197